Impact of comorbidities on outcomes in patients with advanced head and neck cancer undergoing immunotherapy.

Meytal GullerDylan Jacob CooperHosam AlkhatibAditya SuruAngelo BlancaflorChristopher A MarounTristan ThamHailey AllenEden MazzaraJerin ThomasNeha B AminEvan WuDavid W EiseleCarole FakhryDrew PardollTanguy Y SeiwertGangcai ZhuRajarsi Mandal

Published in: Head & neck (2023)

Comorbidity should be considered as a significant prognostic factor in clinical decision-making for patients with advanced HNC undergoing immunotherapy.

Keyphrases

prognostic factors
decision making
type diabetes
adipose tissue
weight loss
glycemic control
insulin resistance